NLRP3 and diabetes mellitus: Zhou et al. [7] found that TXNIP-mediated NLRP3 inflammasome pathway activation is implicated in nervous system inflammation, and related studies have confirmed the correlation of NLRP3 inflammasome with diabetes and its related complications [7, 8].